首页> 美国卫生研究院文献>other >In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013

【2h】

In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013

机译：靶向治疗时代法国转移性肾细胞癌的院内经济负担：2008-2013年法国国家医院数据库的分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background & ObjectivesThe aim of this study was to assess the economic burden of hospitalisations for metastatic renal cell carcinoma (mRCC), to describe the patterns of prescribing expensive drugs and to explore the impact of geographic and socio-demographic factors on the use of these drugs.

机译：背景与目的本研究的目的是评估转移性肾细胞癌（mRCC）的住院治疗的经济负担，描述处方昂贵药物的方式，并探讨地理和社会人口统计学因素对这些药物使用的影响。

著录项

期刊名称 other
作者
Rana Maroun; Franck Maunoury; Laure Benjamin; Gaëlle Nachbaur; Isabelle Durand-Zaleski;
展开▼
作者单位

展开▼
年(卷),期 -1(11),9
年度 -1
页码 e0162864
总页数 13
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium [J] . Wells J. Connor, Stukalin Igor, Norton Craig, European urology . 2017,第2期

机译：第三线靶向治疗转移性肾细胞癌：国际转移性肾细胞癌数据库联盟的结果
2. Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium [J] . Kaymakcalan Marina D., Xie Wanling, Albiges Laurence, Cancer: A Journal of the American Cancer Society . 2016,第3期

机译：血管内皮生长因子靶向疗法治疗转移性肾细胞癌患者的风险因素和预测毒性相关治疗终止的模型：国际转移性肾细胞癌数据库联合会的结果
3. International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study [J] . Ko Jenny J., Xie Wanling, Kroeger Nils, The lancet oncology . 2015,第3期

机译：国际转移性肾细胞癌数据库联合会模型作为先前接受过一线靶向治疗的转移性肾细胞癌患者的预后工具：一项基于人群的研究
4. When to Treat Metastatic Renal Cell Carcinoma Comorbidities, Systemic Therapy, and Active Surveillance in Metastatic Kidney Cancer [C] . Brian I. Rini Genitourinary Cancers Symposium . 2012

机译：何时治疗转移性肾细胞癌的组合，全身治疗，以及在转移性肾癌中的活跃监测
5. Understanding the Attributes of Papillary Renal Cell Carcinoma subtypes: Molecular Analysis, Biomarker Discovery and Implications to Therapy [D] . Saleeb, Rola Magdy Yousef. 2018

机译：了解乳头状肾细胞癌亚型的属性：分子分析，生物标志物发现及其对治疗的意义
6. Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC) [O] . Steven M. Yip, Jose M. Ruiz Morales, Frede Donskov, -1

机译：在靶向治疗时代的转移性嗜铬细胞肾细胞癌（chrRCC）的结果：国际转移性肾细胞癌数据库联盟（IMDC）的结果
7. In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013. [O] . Rana Maroun, Franck Maunoury, Laure Benjamin, 2016

机译：靶向治疗时代法国转移性肾细胞癌住院经济负担：2008年至2013年法国国立医院数据库分析。

In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013

摘要

著录项

相似文献

相关主题

期刊订阅